Van Voorhees, Abby S.
- Professor & Chair Dermatology, Dermatology
Overview
overview
- Abby S. Van Voorhees, M.D., is a professor, chair and residency director of the department of dermatology at the Eastern Virginia Medical School. She obtained her B.A. from Brown University in 1979 in biology and received her M.D. from Yale University in 1983. She completed her dermatology residency at the Yale-New Haven Hospital in 1988, serving as the chief resident from July 1987 to 1988. In addition to her current position, Dr. Van Voorhees has also worked in the University of Pennsylvania Department of Dermatology and the University of Connecticut Department of Medicine. She has been active in clinical research issues in dermatology, particularly those related to the treatment of psoriasis. Dr. Van Voorhees is the chair of the Medical Board of the National Psoriasis Foundation and is also on the Board of Directors of the American Academy of Dermatology. She previously was the Medical Editor of Dermatology World. Additionally, she has served on several of the American Academy of Dermatology's committees and task forces, including serving as the chairman for the Guidelines of Care task force. She is the author of over 90 publications.
Publications
selected publications
-
2021Guidelines for Management of Psoriasis Screening for Comorbidities. JOURNAL OF THE DERMATOLOGY NURSES ASSOCIATION. 13:168-174.Full Text via DOI: 10.1097/JDN.0000000000000618
-
2021Proportions of biologic discontinuation among psoriasis patients with metabolic comorbidities. JOURNAL OF INVESTIGATIVE DERMATOLOGY. S49-S49.
-
2021Drug survival of ixekizumab, TNF inhibitors, and other IL-17 inhibitors in real-world patients with psoriasis: The Corrona Psoriasis Registry. DERMATOLOGIC THERAPY.Full Text via DOI: 10.1111/dth.14808 PMID: 33491259
-
2020Characterization of Insufficient Responders to Ustekinumab in Patients With Moderate-to-Severe Psoriasis in the US Corrona Psoriasis Registry.. JOURNAL OF DERMATOLOGICAL TREATMENT.Full Text via DOI: 10.1080/09546634.2020.1720586 PMID: 32027197
-
2020Efficacy and Safety of Apremilast in Patients With Moderate to Severe Plaque Psoriasis of the Scalp: Results of a Phase 3b, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study.. Journal of the American Academy of Dermatology.Full Text via DOI: 10.1016/j.jaad.2020.01.072 PMID: 32032692
-
2020The National Psoriasis Foundation Psoriasis Treatment Targets in Real World Patients: Prevalence and Association with Patient Reported Outcomes in the Corrona Psoriasis Registry.. Journal of the European Academy of Dermatology and Venereology : JEADV.Full Text via DOI: 10.1111/jdv.16274 PMID: 32027420
-
2020What will keep women practicing dermatology?. International journal of women's dermatology. 5-6.Full Text via DOI: 10.1016/j.ijwd.2019.08.002 PMID: 32025553
-
2019Cutaneous inflammation in the DIAMOND (TM) mouse model of non-alcoholic fatty liver disease. JOURNAL OF INVESTIGATIVE DERMATOLOGY. S84-S84.
-
2019The vascular inflammation in psoriasis (VIP) trial: A secondary analysis of patient reported outcomes for patients treated with adalimumab, phototherapy, or placebo. JOURNAL OF INVESTIGATIVE DERMATOLOGY. S93-S93.
-
2019A systematic review of herpes zoster incidence and consensus recommendations on vaccination in adult patients on systemic therapy for psoriasis or psoriatic arthritis: From the Medical Board of the National Psoriasis Foundation. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 102-110.Full Text via DOI: 10.1016/j.jaad.2019.03.017 PMID: 30885757
-
2019Achievement of the National Psoriasis Foundation Treatment Targets With Ixekizumab: Pooled Analyses From Four Clinical Studies.. Journal of the American Academy of Dermatology.Full Text via DOI: 10.1016/j.jaad.2019.09.030 PMID: 31562945
-
2019An update on generalized pustular psoriasis. EXPERT REVIEW OF CLINICAL IMMUNOLOGY. 907-919.Full Text via DOI: 10.1080/1744666X.2019.1648209 PMID: 31486687
-
2019Characterization of insufficient responders to anti-tumor necrosis factor therapies in patients with moderate to severe psoriasis: real-world data from the US Corrona Psoriasis Registry.. The Journal of dermatological treatment. 1-8.Full Text via DOI: 10.1080/09546634.2019.1656797 PMID: 31581919
-
2019Patient-reported outcomes of adalimumab, phototherapy, and placebo in the Vascular Inflammation in Psoriasis Trial: A randomized controlled study. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 81:923-930.Full Text via DOI: 10.1016/j.jaad.2019.05.080 PMID: 31163241
-
2019Peripheral Retinal Vascular Leakage in Moderate to Severe Psoriasis: A Pilot Study.. Journal of the American Academy of Dermatology.Full Text via DOI: 10.1016/j.jaad.2019.05.067 PMID: 31150713
-
2019Severe scurvy in an adult male without clear risk factors for nutritional deficiency.. JAAD case reports. 309-311.Full Text via DOI: 10.1016/j.jdcr.2019.01.031 PMID: 30989097
-
2019Special Article: 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis. ARTHRITIS & RHEUMATOLOGY. 71:5-32.Full Text via DOI: 10.1002/art.40726 PMID: 30499246
-
2019Special Article: 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis. ARTHRITIS CARE & RESEARCH. 71:2-29.Full Text via DOI: 10.1002/acr.23789 PMID: 30499259
-
2018Characterization of nonresponders to anti-TNFs in moderate-to-severe psoriasis patients in routine clinical practices in the US. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. AB69-AB69.
-
2018Patient profile of nonresponders to ustekinumab in moderate-to-severe psoriasis patients enrolled in the Corrona Psoriasis Registry. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. AB216-AB216.
-
2018Psoriasis patients achieving National Psoriasis Foundation Treat-to-Target goals and associated quality of life improvement in the Corrona Psoriasis Registry cohort. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. AB234-AB234.
-
2018Symptom relapse following apremilast discontinuation is related to longer disease duration at treatment initiation in patients with moderate-to-severe psoriasis. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. AB277-AB277.
-
2018Dietary Recommendations for Adults With Psoriasis or Psoriatic Arthritis From the Medical Board of the National Psoriasis Foundation A Systematic Review. JAMA DERMATOLOGY. 934-950.Full Text via DOI: 10.1001/jamadermatol.2018.1412 PMID: 29926091
-
2018Effect of 2 Psoriasis Treatments on Vascular Inflammation and Novel Inflammatory Cardiovascular Biomarkers A Randomized Placebo-Controlled Trial. CIRCULATION-CARDIOVASCULAR IMAGING. 11.Full Text via DOI: 10.1161/CIRCIMAGING.117.007394 PMID: 29776990
-
2018Management of psoriasis in patients with inflammatory bowel disease: From the Medical Board of the National Psoriasis Foundation. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 383-394.Full Text via DOI: 10.1016/j.jaad.2017.06.043 PMID: 29332708
-
2018A COMPREHENSIVE SURVEY ASSESSING THE FAMILY PLANNING NEEDS OF WOMEN WITH PSORIASIS. ACTA DERMATO-VENEREOLOGICA. 56-57.
-
2018Psoriasis in solid organ transplant patients: best practice recommendations from The Medical Board of the National Psoriasis Foundation. JOURNAL OF DERMATOLOGICAL TREATMENT. 29:329-333.Full Text via DOI: 10.1080/09546634.2017.1373737 PMID: 28884635
-
2017Treatment of Inverse/Intertriginous Psoriasis: Updated Guidelines from the Medical Board of the National Psoriasis Foundation. JOURNAL OF DRUGS IN DERMATOLOGY. 16:760-766.
-
2017Pediatric Psoriasis Comorbidity Screening Guidelines. JAMA DERMATOLOGY. 698-704.Full Text via DOI: 10.1001/jamadermatol.2017.0499 PMID: 28514463
-
2017Psoriasis and comorbid diseases Epidemiology. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 377-390.Full Text via DOI: 10.1016/j.jaad.2016.07.064 PMID: 28212759
-
2017From the Medical Board of the National Psoriasis Foundation: Treatment targets for plaque psoriasis. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 76:290-298.Full Text via DOI: 10.1016/j.jaad.2016.10.017 PMID: 27908543
-
2017Diversity in Dermatology Residency Programs.. The journal of investigative dermatology. Symposium proceedings. S46-S49.Full Text via DOI: 10.1016/j.jisp.2017.07.001 PMID: 28941493
-
2017Psoriasis and comorbid diseases Implications for management. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 393-403.Full Text via DOI: 10.1016/j.jaad.2016.07.065 PMID: 28212760
-
2017Treatment of Inverse/Intertriginous Psoriasis: Updated Guidelines from the Medical Board of the National Psoriasis Foundation. JOURNAL OF DRUGS IN DERMATOLOGY. 16:760-766.PMID: 28809991
-
2016From the Medical Board of the National Psoriasis Foundation: Perioperative management of systemic immunomodulatory agents in patients with psoriasis and psoriatic arthritis. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 798-U254.Full Text via DOI: 10.1016/j.jaad.2016.06.014 PMID: 27461230
-
2016Factors associated with biopsy site identification, postponement of surgery, and patient confidence in a dermatologic surgery practice. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 74:1185-1193.Full Text via DOI: 10.1016/j.jaad.2015.12.019 PMID: 26853178
-
2016Research objectives and design of the Corrona Psoriasis Registry: A large prospective cohort of psoriasis patients in the United States. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. AB268-AB268.
-
2016US Perspectives in the Management of Psoriasis and Psoriatic Arthritis: Patient and Physician Results from the Population-Based Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) Survey. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY. 17:87-97.Full Text via DOI: 10.1007/s40257-015-0169-x PMID: 26718712
-
2016Severe Small-Vessel Vasculitis Temporally Associated With Administration of Ustekinumab.. JOURNAL OF DRUGS IN DERMATOLOGY. 359-62.PMID: 26954323
-
2015Annual screening for tuberculosis in patients on TNF-alfa antagonists. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. E123-E123.Full Text via DOI: 10.1016/j.jaad.2015.04.071 PMID: 26282816
-
2015Combining Biologic TherapiesWith Other Systemic Treatments in Psoriasis Evidence-Based, Best-Practice Recommendations From the Medical Board of the National Psoriasis Foundation. JAMA DERMATOLOGY. 432-438.Full Text via DOI: 10.1001/jamadermatol.2014.3456 PMID: 25517130
-
2015Phototherapy in dermatology: A call for action. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 1078-1080.Full Text via DOI: 10.1016/j.jaad.2015.03.017 PMID: 25981004
-
2015Reply to: "Time to update guidelines on screening for latent tuberculosis infection in dermatologic patients being treated with tumor necrosis factor-alfa inhibitors''. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 744-744.Full Text via DOI: 10.1016/j.jaad.2014.08.056 PMID: 25773422
-
2015Treatment of Nail Psoriasis Best Practice Recommendations From the Medical Board of the National Psoriasis Foundation. JAMA DERMATOLOGY. 151:87-94.Full Text via DOI: 10.1001/jamadermatol.2014.2983 PMID: 25471223
-
2015Validity of the Simple-Measure for Assessing Psoriasis Activity (S-MAPA) for objectively evaluating disease severity in patients with plaque psoriasis. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 868-870.Full Text via DOI: 10.1016/j.jaad.2015.07.001 PMID: 26475541
-
2014Comparative effectiveness of less commonly used systemic monotherapies and common combination therapies for moderate to severe psoriasis in the clinical setting. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 71:1167-1175.Full Text via DOI: 10.1016/j.jaad.2014.08.003 PMID: 25260564
-
2014From the Medical Board of the National Psoriasis Foundation: Recommendations for screening for hepatitis B infection prior to initiating anti-tumor necrosis factor-alfa inhibitors or other immunosuppressive agents in patients with psoriasis. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 70:178-186.Full Text via DOI: 10.1016/j.jaad.2013.08.049 PMID: 24220724
-
2014From the Medical Board of the National Psoriasis Foundation: The risk of cardiovascular disease in individuals with psoriasis and the potential impact of current therapies. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 168-177.Full Text via DOI: 10.1016/j.jaad.2013.09.020 PMID: 24184141
-
2014Palmoplantar psoriasis is associated with greater impairment of health-related quality of life compared with moderate to severe plaque psoriasis. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 71:623-632.Full Text via DOI: 10.1016/j.jaad.2014.04.063 PMID: 24894455
-
2014Patient satisfaction with treatments for moderate-to-severe plaque psoriasis in clinical practice. BRITISH JOURNAL OF DERMATOLOGY. 170:672-680.Full Text via DOI: 10.1111/bjd.12745 PMID: 24266717
-
2014Patient-reported outcomes for psoriasis patients with clear versus almost clear skin in the clinical setting. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 71:633-641.Full Text via DOI: 10.1016/j.jaad.2014.05.001 PMID: 24928705
-
2014Psoriasis is associated with decreased plasma adiponectin levels independently of cardiometabolic risk factors. CLINICAL AND EXPERIMENTAL DERMATOLOGY. 39:19-24.Full Text via DOI: 10.1111/ced.12250 PMID: 24341476
-
2014Research gaps in psoriasis: Opportunities for future studies. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 70:146-167.Full Text via DOI: 10.1016/j.jaad.2013.08.042 PMID: 24126079
-
2013Early development and qualitative evidence of content validity for the Psoriasis Symptom Inventory (PSI), a patient-reported outcome measure of psoriasis symptom severity. JOURNAL OF DERMATOLOGICAL TREATMENT. 24:255-260.Full Text via DOI: 10.3109/09546634.2012.759639 PMID: 23249143
-
2013From the Medical Board of the National Psoriasis Foundation: Vaccination in adult patients on systemic therapy for psoriasis. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 1003-1013.Full Text via DOI: 10.1016/j.jaad.2013.06.046 PMID: 24075223
-
2013Patient-reported reasons for the discontinuation of commonly used treatments for moderate to severe psoriasis. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 68:64-72.Full Text via DOI: 10.1016/j.jaad.2012.06.035 PMID: 22846688
-
2013TSLP Elicits IL-33-Independent Innate Lymphoid Cell Responses to Promote Skin Inflammation. SCIENCE TRANSLATIONAL MEDICINE. 5.Full Text via DOI: 10.1126/scitranslmed.3005374 PMID: 23363980
-
2013Using Hawthorne Effects to Improve Adherence in Clinical Practice: Lessons From Clinical Trials Reply. JAMA DERMATOLOGY. 491-491.Full Text via DOI: 10.1001/jamadermatol.2013.2846 PMID: 23715064
-
2013Variation in dermatologist beliefs about the safety and effectiveness of treatments for moderate to severe psoriasis. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 68:262-269.Full Text via DOI: 10.1016/j.jaad.2012.07.007 PMID: 22910105
-
2012Comparative Effectiveness of Commonly Used Systemic Treatments or Phototherapy for Moderate to Severe Plaque Psoriasis in the Clinical Practice Setting. ARCHIVES OF DERMATOLOGY. 148:487-494.Full Text via DOI: 10.1001/archdermatol.2012.370 PMID: 22508874
-
2012Consensus Guidelines for the Management of Plaque Psoriasis. ARCHIVES OF DERMATOLOGY. 148:95-102.Full Text via DOI: 10.1001/archdermatol.2011.1410 PMID: 22250239
-
2012Dermatologist Preferences for Treatments to Compare in Future Randomized Controlled Comparative Effectiveness Trials for Moderate to Severe Psoriasis. ARCHIVES OF DERMATOLOGY. 539-541.Full Text via DOI: 10.1001/archdermatol.2011.1399 PMID: 22508884
-
2012Dermatologist preferences for first-line therapy of moderate to severe psoriasis in healthy adult patients. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 66:376-386.Full Text via DOI: 10.1016/j.jaad.2011.03.012 PMID: 21856040
-
2012Review of treatment options for psoriasis in pregnant or lactating women: From the Medical Board of the National Psoriasis Foundation. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 459-477.Full Text via DOI: 10.1016/j.jaad.2011.07.039 PMID: 22018758
-
2012The impact of psoriasis on 10-year Framingham risk. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 796-798.Full Text via DOI: 10.1016/j.jaad.2012.05.016 PMID: 22739354
-
2012Treatment of pustular psoriasis: From the Medical Board of the National Psoriasis Foundation. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 279-288.Full Text via DOI: 10.1016/j.jaad.2011.01.032 PMID: 22609220
-
2011Guidelines of care for the management of psoriasis and psoriatic arthritis. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 65:137-174.Full Text via DOI: 10.1016/j.jaad.2010.11.055 PMID: 21306785
-
2011In response to "Treatment of psoriasis with cyclosporine in patients with hepatitis C infection: Risk or opportunity?". JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 788-790.Full Text via DOI: 10.1016/j.jaad.2010.10.033 PMID: 21414501
-
2011Psoriasis in the elderly: From the Medical Board of the National Psoriasis Foundation. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 65:537-545.Full Text via DOI: 10.1016/j.jaad.2010.05.014 PMID: 21496950
-
2011Systemic and Vascular Inflammation in Patients With Moderate to Severe Psoriasis as Measured by [18F]-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography (FDG-PET/CT). ARCHIVES OF DERMATOLOGY. 147:1031-1039.Full Text via DOI: 10.1001/archdermatol.2011.119 PMID: 21576552
-
2011Treatment of Refractory Tumor Necrosis Factor Inhibitor-Induced Palmoplantar Pustulosis: A Report of 2 Cases. ARCHIVES OF DERMATOLOGY. 1228-1230.Full Text via DOI: 10.1001/archdermatol.2011.275 PMID: 22006150
-
2010Guidelines of care for the management of psoriasis and psoriatic arthritis Section 5. Guidelines of care for the treatment of psoriasis with phototherapy and photochemotherapy. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 114-135.Full Text via DOI: 10.1016/j.jaad.2009.08.026 PMID: 19811850
-
2010Obesity and psoriasis: From the Medical Board of the National Psoriasis Foundation. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 1058-1069.Full Text via DOI: 10.1016/j.jaad.2009.09.053 PMID: 20692722
-
2010Potentially modifiable risk factors for adverse pregnancy outcomes in women with psoriasis. BRITISH JOURNAL OF DERMATOLOGY. 163:334-339.Full Text via DOI: 10.1111/j.1365-2133.2010.09899.x PMID: 20545678
-
2010Psoriasis in patients with HIV infection: From the Medical Board of the National Psoriasis Foundation. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 291-299.Full Text via DOI: 10.1016/j.jaad.2009.03.047 PMID: 19646777
-
2010Treatment of erythrodermic psoriasis: From the medical board of the National Psoriasis Foundation. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 655-662.Full Text via DOI: 10.1016/j.jaad.2009.05.048 PMID: 19665821
-
2007National Psoriasis Foundation clinical consensus on disease severity. ARCHIVES OF DERMATOLOGY. 143:239-242.
Research
research overview
- My research interests center on the study of psoriasis, both its response to treatment as well as the comorbid diseases that often accompany this disease.
projects
Contact
preferred title
- Professor & Chair Dermatology
full name
- Abby S. Van Voorhees, MD